Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119(25):3198–206.

Article  CAS  PubMed  Google Scholar 

Palmerini T, Biondi Zoccali G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379(9824):1393–402.

Article  CAS  PubMed  Google Scholar 

Nakazawa G, Finn AV, Joner M, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118(11):1138–45.

Article  PubMed  Google Scholar 

Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–30.

Article  CAS  PubMed  Google Scholar 

Muhlestein JB. Endothelial dysfunction associated with drug-eluting stents what, where, when, and how? J Am Coll Cardiol. 2008;51(22):2139–40.

Article  CAS  PubMed  Google Scholar 

Scheller B, Speck U, Schmitt A, et al. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003;42(8):1415–20.

Article  CAS  PubMed  Google Scholar 

Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.

Article  PubMed  Google Scholar 

Megaly M, Buda K, Saad M, et al. Outcomes with drug-coated balloons vs. drug-eluting stents in small-vessel coronary artery disease. Cardiovasc Revasc Med. 2022;35:76–82.

Article  PubMed  Google Scholar 

Sanz Sánchez J, Chiarito M, Cortese B, et al. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: a meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2021;98(1):66–75.

Article  PubMed  Google Scholar 

Yu X, Ji F, Xu F, et al. Treatment of large de novo coronary lesions with paclitaxel-coated balloon: results from a Chinese institute. Clin Res Cardiol. 2019;108(3):234–43.

Article  CAS  PubMed  Google Scholar 

Nishiyama N, Komatsu T, Kuroyanagi T, et al. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardiol. 2016;222:113–8.

Article  PubMed  Google Scholar 

Gobić D, Tomulić V, Lulić D, et al. Drug-coated balloon versus drug-eluting stent in primary percutaneous coronary intervention: a feasibility study. Am J Med Sci. 2017;354(6):553–60.

Article  PubMed  Google Scholar 

Scheller B, Ohlow MA, Ewen S, et al. Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial. EuroIntervention. 2020;15(17):1527–33.

Article  PubMed  Google Scholar 

Hao X, Huang D, Wang Z, et al. Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction. J Cardiothorac Surg. 2021;16(1):178.

Article  PubMed  Google Scholar 

Nicola SR, Vos NS, Van Der Schaaf RJ, et al. Two-year clinical outcomes of the REVELATION Study: sustained safety and feasibility of paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction. J Invasive Cardiol. 2022;34(1):39–42.

Google Scholar 

Yu X, Wang X, Ji F, et al. A non-inferiority, randomized clinical trial comparing paclitaxel-coated balloon versus new-generation drug-eluting stents on angiographic outcomes for coronary de novo lesions. Cardiovasc Drugs Ther. 2022;36(4):655–64.

Article  CAS  PubMed  Google Scholar 

Wang Z, Yin Y, Li J, et al. New Ultrasound-controlled paclitaxel releasing balloon vs. asymmetric drug-eluting stent in primary ST-segment elevation myocardial infarction - a prospective randomized trial. Circ J. 2022;86(4):642–50.

Article  CAS  PubMed  Google Scholar 

Parums DV. Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit. 2021;27:e934475.

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT, Altman DG, Sterne JAC. Assessing the risk of bias in the included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. London: The Cochrane Collaboration; 2011.

Google Scholar 

Weiss AJ, Lorente-Ros M, Correa A, et al. Recent advances in stent technology: Do they reduce cardiovascular events? Curr Atheroscler Rep. 2022;24(9):731–44.

Article  CAS  PubMed  Google Scholar 

Cao Z, Li J, Fang Z, et al. The factors influence the efficiency of drug-coated balloons. Front Cardiovasc Med. 2022;9:947776.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maupas E, Lipiecki J, Levy R, et al. Safety and efficacy outcomes of 3rd generation DES in an all-comer population of patients undergoing PCI: 12-month and 24-month results of the e-Biomatrix French registry. Catheter Cardiovasc Interv. 2017;90(6):890–7.

Article  PubMed  PubMed Central  Google Scholar 

Pan L, Lu W, Han Z, et al. Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study. Clin Res Cardio. 2022;111(7):732–41.

Article  CAS  Google Scholar 

Meunier L, Godin M, Southerland G, et al. Prospective, single-center evaluation of the safety and efficacy of percutaneous coronary interventions following a decision tree proposing a no-stent strategy in stable patients with coronary artery disease (SCRAP study). Clin Res Cardiol. 2022;112(9):1164–74.

Article  PubMed  PubMed Central  Google Scholar 

Rosenberg M, Waliszewski M, Chin K, et al. Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: the DCB-only All-Comers Registry. Catheter Cardiovasc Interv. 2019;93(2):181–8.

Article  PubMed  Google Scholar 

Merinopoulos I, Gunawardena T, Wickramarachchi U, et al. Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study. Clin Res Cardiol. 2021;110(2):220–7.

Article  CAS  PubMed  Google Scholar 

Merinopoulos I, Gunawardena T, Corballis N, et al. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice. Clin Res Cardiol. 2022;112(9):1186–93.

Article  PubMed  PubMed Central  Google Scholar 

Gunawardena TD, Corballis N, Merinopoulos I, et al. Drug-coated balloon vs. drug-eluting stents for de novo unprotected left main stem disease: The SPARTAN-LMS study. J Cardiovasc Dev Dis. 2023;10(2):84.

CAS  PubMed  PubMed Central  Google Scholar 

Yang YX, He KZ, Li JY, et al. Comparisons of drug-eluting balloon versus drug-eluting stent in the treatment of young patients with acute myocardial infarction. J Cardiovasc Dev Dis. 2023;10(1):29.

CAS  PubMed  PubMed Central  Google Scholar 

Lin Y, Sun X, Liu H, et al. Drug-coated balloon versus drug-eluting stents for treating de novo coronary lesions in large vessels: a meta-analysis of clinical trials. Herz. 2021;46(3):269–76. English

Article  PubMed  Google Scholar